AU Patent

AU5698094A — Antisense nucleic acid for the treatment of diseases in which expression of bfgf, pdgf-a or pdgf-b plays a pathogenic role

Assigned to Biognostik Gesellschaft fuer Biomolekulare Diagnostik mbH · Expires 1995-06-27 · 31y expired

What this patent protects

Patent listed against avacincaptad-pegol-sodium.

Drugs covered by this patent

Patent Metadata

Patent number
AU5698094A
Jurisdiction
AU
Classification
—
Expires
1995-06-27
Drug substance claim
No
Drug product claim
No
Assignee
Biognostik Gesellschaft fuer Biomolekulare Diagnostik mbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.